Biotech in Israel: Holding on to business as usual amid uncertain times
In the middle of our Zoom interview, Mati Gill, Tel Aviv-based CEO of venture studio AION Labs, excused himself calmly to find shelter when a siren started to run amok in the background. After five minutes, he returned and said: “I have to show an example for the kids — so I can’t skip out on running to the shelter.”
After militant group Hamas made attacks with thousands of rockets on Saturday, Israel has since declared a state of war. The events prompted words of support from pharma industry figureheads such as Pfizer CEO Albert Bourla, with Israel-based companies such as Teva reassuring observers that it doesn’t anticipate an impact on its business and operations.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.